Interestingly, the receptor GC-C has been also demonstrated as a tumor suppressor, and has emerged as a promising target for intestinal and pancreatic cancer (Kloeters et al., 2008; Aka et al., 2017). This evidence concerns the gene GUCY2C and neoplasm.